Defining clinically interpretable glycemic profiles using continuous glucose monitoring in type 2 diabetes
Abstract
The American Diabetes Association (ADA) recommends continuous glucose monitoring (CGM) metrics for monitoring glucose control, including time in range (TIR 70–180 mg/dL), time below range (TBR 250 mg/dL), mean glucose, glucose coefficient of variation (CV) (1). Cluster analysis of these clinical CGM metrics may help us uncover distinct glycemic subgroups.
Fields of Study & Subjects
Diabetes Management and Research
Diabetes Treatment and Management
Diabetes Management and Education
Publication details
- Publication date
- 9 January 2026